Lynn E. Heasley

11.1k total citations · 2 hit papers
141 papers, 9.2k citations indexed

About

Lynn E. Heasley is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lynn E. Heasley has authored 141 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 47 papers in Oncology and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lynn E. Heasley's work include Lung Cancer Treatments and Mutations (32 papers), Protein Kinase Regulation and GTPase Signaling (30 papers) and Fibroblast Growth Factor Research (19 papers). Lynn E. Heasley is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Protein Kinase Regulation and GTPase Signaling (30 papers) and Fibroblast Growth Factor Research (19 papers). Lynn E. Heasley collaborates with scholars based in United States, Germany and Japan. Lynn E. Heasley's co-authors include Gary L. Johnson, Raphael A. Nemenoff, Raphael A. Nemenoff, Sunil Gupta, Lindsay A. Marek, Robert C. Doebele, Vicki Van Putten, Laura Butterfield, Wilbur A. Franklin and Carol L. Sable and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lynn E. Heasley

140 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer

2012 820 citations Robert C. Doebele, Amanda Pilling et al. Clinical Cancer Research profile →
Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein

2000 697 citations Lynn E. Heasley et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Lynn E. Heasley

Since Specialization

Citations

This map shows the geographic impact of Lynn E. Heasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. Heasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. Heasley more than expected).

Fields of papers citing papers by Lynn E. Heasley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. Heasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. Heasley. The network helps show where Lynn E. Heasley may publish in the future.

Co-authorship network of co-authors of Lynn E. Heasley

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn E. Heasley. A scholar is included among the top collaborators of Lynn E. Heasley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn E. Heasley. Lynn E. Heasley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes 2023 ·Biology Open ·Laura Schubert, Anh‐Tuan Le, Trista K. Hinz, Andre Navarro, (unknown), Raphael A. Nemenoff, Lynn E. Heasley, Robert C. Doebele	2
2	Upregulation of complement proteins in lung cancer cells mediates tumor progression 2023 ·Frontiers in Oncology ·Emily K. Kleczko, Joanna M. Poczobutt, Andre Navarro, Jennifer Laskowski, Amber M. Johnson, (unknown), (unknown), Lynn E. Heasley, Katharina Hopp, Mary C. Weiser-Evans, Elizabeth B. Gottlin, (unknown), Michael J. Campa, Edward F. Patz, Joshua M. Thurman, Raphael A. Nemenoff	6
3	TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin 2021 ·Molecular Pharmacology ·Trista K. Hinz, (unknown), (unknown), (unknown), Lynn E. Heasley	8
4	Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms 2020 ·Journal for ImmunoTherapy of Cancer ·Alexander Neuwelt, Abigail K. Kimball, Amber M. Johnson, (unknown), Bonnie Bullock, Rachael E. Kaspar, Emily K. Kleczko, Jeff Kwak, Meng‐Han Wu, Lynn E. Heasley, Robert C. Doebele, Howard Li, Raphael A. Nemenoff, Eric T. Clambey	37
5	Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers 2018 ·Clinical Cancer Research ·Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, Ayman Oweida, Shelby Lennon, Andy V. Phan, (unknown), (unknown), Antonio Jimeno, David Raben, Hilary Somerset, Lynn E. Heasley, Sana D. Karam	23
6	Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration 2018 ·Clinical Cancer Research ·Ayman Oweida, Mohammad K. Hararah, Andy V. Phan, David C. Binder, Shilpa Bhatia, Shelby Lennon, Sanjana Bukkapatnam, Benjamin Van Court, (unknown), Laurel B. Darragh, H. Mike Kim, David Raben, Aik Choon Tan, Lynn E. Heasley, Eric T. Clambey, Raphael A. Nemenoff, Sana D. Karam	209
7	Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor 2018 ·Molecular Cancer Therapeutics ·Shilpa Bhatia, (unknown), Shelby Lennon, Ayman Oweida, Jaspreet Sharma, (unknown), (unknown), Sanjana Bukkapatnam, Benjamin Van Court, David Raben, Christian D. Young, Lynn E. Heasley, Sana D. Karam	9
8	The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade 2017 ·Cancer Immunology Research ·Howard Li, Maria McSharry, Bonnie Bullock, Teresa T. Nguyen, Jeff Kwak, Joanna M. Poczobutt, Trisha R. Sippel, Lynn E. Heasley, Mary C. Weiser-Evans, Eric T. Clambey, Raphael A. Nemenoff	128
9	EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases 2017 ·Cancer Research ·Aria Vaishnavi, Laura Schubert, Uwe Rix, Lindsay A. Marek, Anh T. Le, Stephen B. Keysar, Magdalena J. Glogowska, Matthew A. Smith, Severine Kako, Natália J. Sumi, Kurtis D. Davies, Kathryn E. Ware, Marileila Varella‐Garcia, Eric B. Haura, Antonio Jimeno, Lynn E. Heasley, Dara L. Aisner, Robert C. Doebele	61
10	Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma 2015 ·Cancer Prevention Research ·Daniel T. Merrick, Dexiang Gao, York E. Miller, Robert L. Keith, Anna E. Barón, William J. Feser, Timothy C. Kennedy, Patrick J. Blatchford, (unknown), Fred R. Hirsch, Lynn E. Heasley, Paul A. Bunn, Wilbur A. Franklin	24
11	Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC 2015 ·Cancer Research ·Katherine R. Singleton, Trista K. Hinz, Emily K. Kleczko, Lindsay A. Marek, Jeff Kwak, (unknown), Jihye Kim, Aik Choon Tan, Lynn E. Heasley	47
12	Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy 2014 ·Bioinformatics ·Jihye Kim, Vihas T. Vasu, Rangnath Mishra, Katherine R. Singleton, Minjae Yoo, Sonia M. Leach, (unknown), Robert J. Mason, Jaewoo Kang, Preveen Ramamoorthy, Jeffrey A. Kern, Lynn E. Heasley, James H. Finigan, Aik Choon Tan	21
13	Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma 2014 ·Molecular Cancer Research ·Lindsay A. Marek, Trista K. Hinz, Anne von Mäßenhausen, (unknown), Emily K. Kleczko, Diana Boehm, Mary C. Weiser-Evans, Raphael A. Nemenoff, Hans Hoffmann, Arne Warth, Joseph M. Gozgit, Sven Perner, Lynn E. Heasley	33
14	FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies 2014 ·Clinical Cancer Research ·Murry W. Wynes, Trista K. Hinz, Dexiang Gao, Michael L. Martini, Lindsay A. Marek, Kathryn E. Ware, (unknown), Diana Böhm, Sven Perner, Barbara A. Helfrich, Rafał Dziadziuszko, Jacek Jassem, Szymon Wojtylak, Aleksandra Sejda, Joseph M. Gozgit, Paul A. Bunn, D. Ross Camidge, Aik Choon Tan, Fred R. Hirsch, Lynn E. Heasley	125
15	Hypoxia Regulates Alternative Splicing of HIF and non-HIF Target Genes 2014 ·Molecular Cancer Research ·(unknown), Liyi Wang, Lynn E. Heasley, Cheng‐Jun Hu	46
16	Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma 2014 ·Carcinogenesis ·Andreas Schröck, (unknown), Friederike Göke, Petra M. Bareiss, Rebekka Schairer, Hui Wang, Wilko Weichert, Alina Franzen, Robert Kirsten, Tobias Van Bremen, Angela Queisser, Glen Kristiansen, Lynn E. Heasley, Friedrich Bootz, Claudia Lengerke, Sven Perner	64
17	Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer breakdown → 2012 ·Clinical Cancer Research ·Robert C. Doebele, Amanda Pilling, Dara L. Aisner, Tatiana G. Kutateladze, Anh T. Le, Andrew Weickhardt, Kimi Kondo, Derek J. Linderman, Lynn E. Heasley, Wilbur A. Franklin, Marileila Varella‐Garcia, D. Ross Camidge	820
18	Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung Tumors 2011 ·Cancer Research ·(unknown), Angela M. Ohm, (unknown), Lynn E. Heasley, Theresa A. Boyle, Wilbur A. Franklin, Mary E. Reyland	45
19	Isoforms of Jun Kinase Are Differentially Expressed and Activated in Human Monocyte/Macrophage (THP-1) Cells 2001 ·The Journal of Immunology ·Stephen C. Dreskin, Gregory W. Thomas, (unknown), Lynn E. Heasley	86
20	Induction of Cytosolic Phospholipase A2 by Oncogenic Ras Is Mediated through the JNK and ERK Pathways in Rat Epithelial Cells 2001 ·Journal of Biological Chemistry ·Vicki Van Putten, (unknown), (unknown), Stacy A. Blaine, Marilee J. Wick, Laura Butterfield, Sun‐Young Han, Lynn E. Heasley, Raphael A. Nemenoff	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact